The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 1
  • Taslaq, Adam Masoud
    Director born in September 1984
    Individual (14 offsprings)
    Officer
    2023-06-05 ~ now
    OF - Director → CIF 0
    Mr Adam Masoud Taslaq
    Born in September 1984
    Individual (14 offsprings)
    Person with significant control
    2023-06-05 ~ now
    PE - Ownership of shares – 75% or moreCIF 0
    PE - Ownership of voting rights - 75% or moreCIF 0
    PE - Right to appoint or remove directorsCIF 0
parent relation
Company in focus

BELGRAVIA PHARMA LTD

Standard Industrial Classification
46460 - Wholesale Of Pharmaceutical Goods
Brief company account
Property, Plant & Equipment
518 GBP2024-06-30
Debtors
78,683 GBP2024-06-30
Cash at bank and in hand
9,162 GBP2024-06-30
Current Assets
87,845 GBP2024-06-30
Creditors
Current, Amounts falling due within one year
-58,768 GBP2024-06-30
Net Current Assets/Liabilities
29,077 GBP2024-06-30
Total Assets Less Current Liabilities
29,595 GBP2024-06-30
Equity
Called up share capital
100 GBP2024-06-30
Retained earnings (accumulated losses)
29,495 GBP2024-06-30
Equity
29,595 GBP2024-06-30
Average Number of Employees
02023-06-05 ~ 2024-06-30
Property, Plant & Equipment - Gross Cost
Other
690 GBP2024-06-30
0 GBP2023-06-04
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Other
172 GBP2024-06-30
0 GBP2023-06-04
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Other
172 GBP2023-06-05 ~ 2024-06-30
Property, Plant & Equipment
Other
518 GBP2024-06-30
Trade Debtors/Trade Receivables
Current
42,672 GBP2024-06-30
Other Debtors
Amounts falling due within one year
36,011 GBP2024-06-30
Debtors
Current, Amounts falling due within one year
78,683 GBP2024-06-30
Trade Creditors/Trade Payables
Current
3,924 GBP2024-06-30
Corporation Tax Payable
Current
6,815 GBP2024-06-30
Other Taxation & Social Security Payable
Current
1,939 GBP2024-06-30
Other Creditors
Current
46,090 GBP2024-06-30
Creditors
Current
58,768 GBP2024-06-30

  • BELGRAVIA PHARMA LTD
    Info
    Registered number 14913834
    Unit 7 Sutherland Court, Brownfields, Welwyn Garden City AL7 1BJ
    Private Limited Company incorporated on 2023-06-05 (2 years 1 month). The company status is Active.
    The last date of confirmation statement was made at 2024-06-04
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.